Masako Takikawa

Characterization of a MAGE-1-derived HLA-A24 epitope-specific CTL line from a Japanese metastatic melanoma patient.

A. Iizuka, K. Yamaguchi, Y. Akiyama, 2009, Anticancer research.

Identification of melanoma‐specific serological markers using proteomic analyses

T. Ashizawa, K. Yamaguchi, Y. Akiyama, 2009 .

Proteomic analysis of a highly metastatic gastric cancer cell line using two-dimensional differential gel electrophoresis.

F. Liu, K. Yamaguchi, Y. Akiyama, 2006, Oncology reports.

Novel approach to the characterization of melanoma associated-peptide-specific CTL lines from Japanese metastatic melanoma patients.

K. Yamaguchi, Y. Akiyama, Sachiko Tai, 2008, International journal of oncology.

Dendritic cell-based vaccination in metastatic melanoma patients: Phase II clinical trial

T. Ashizawa, A. Iizuka, H. Miyata, 2012, Oncology reports.

Characterization of cytomegalovirus pp65-HLA-A24 peptide-specific CTL lines from metastatic melanoma patients.

Y. Akiyama, Masaru Komiyama, Sachiko Tai, 2009, Oncology reports.

Suppression of GD1α ganglioside‐mediated tumor metastasis by liposomalized WHW‐peptide

N. Oku, T. Asai, N. Yamaguchi, 2000, FEBS letters.

Identification of melanoma antigens using a Serological Proteome Approach (SERPA).

Yoshio Kiyohara, Naoya Yamazaki, Akira Iizuka, 2010, Cancer genomics & proteomics.